News: Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

190.06USD
31 Oct 2014
Price Change (% chg)

$0.62 (+0.33%)
Prev Close
$189.44
Open
$190.00
Day's High
$191.87
Day's Low
$189.05
Volume
318,349
Avg. Vol
304,827
52-wk High
$192.60
52-wk Low
$88.34

Search Stocks
Select another date:

Mon, Oct 27 2014

Photo

Valeant ready to raise Allergan bid to at least $200/share

- Valeant Pharmaceuticals International Inc on Monday said in a letter to Allergan Inc's board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of doing so.

UPDATE 3-Valeant says ready to raise Allergan bid to at least $200/share

Oct 27 - Valeant Pharmaceuticals International Inc on Monday said in a letter to Allergan Inc's board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of doing so.

Valeant says ready to raise Allergan bid to at least $200/share

Oct 27 - Valeant Pharmaceuticals International Inc said it is prepared to improve its offer for Allergan Inc to at least $200 per share.

COLUMN-New details in Allergan anti-takeover campaign: Frankel

(The opinions expressed here are those of Alison Frankel, a columnist for Reuters.)

Stronger oil stocks and surge in Shire lift UK's FTSE

LONDON, Oct 21 - Gains in big oil companies and drugmaker Shire lifted Britain's top equity index on Tuesday, which extended a rebound after falling to 15-month lows last week.

Allergan says it stands by statements on Valeant

BOSTON - Allergan Inc said on Tuesday it saw no evidence to support claims by hostile suitors Valeant Pharmaceuticals and hedge fund Pershing Square Capital Management that its chief executive officer had spearheaded a campaign to spread misinformation.

UPDATE 1-Allergan says it stands by statements on Valeant

BOSTON, Oct 21 - Allergan Inc said on Tuesday it saw no evidence to support claims by hostile suitors Valeant Pharmaceuticals and hedge fund Pershing Square Capital Management that its chief executive officer had spearheaded a campaign to spread misinformation.

Allergan says it stands by statements on Valeant

BOSTON, Oct 21 - Allergan Inc said on Tuesday that it believes there is no evidence to support Valeant Pharmaceuticals and hedge fund Pershing Square Capital Management's claims that its chief executive officer spearheaded a campaign to spread misinformation about Valeant.

Gains in oil stocks and Shire lift UK's FTSE

* FTSE 100 up 1.4 pct, continues rebound off 15-month lows

Gains in oil stocks and Shire lift UK's FTSE

LONDON, Oct 21 - A rise in major oil stocks and drugmaker Shire helped Britain's top equity index extend its rebound on Tuesday after falling to 15-month lows last week.

Select another date:
Search Stocks